Skip to content
Research Article Open access CC BY 4.0

Advances in Molecular Diagnosis and Personalized Treatment of Soft Tissue Sarcomas

Gamal Abdul Hamid, Fadhel Hariri, Mauro Luisetto

International Research Journal of Oncology · pp. 239–259 · Published 7 Nov 2024

Abstract

Soft tissue tumors are a diverse range of diagnostic entities including the majority of them benign in nature and behavior. Soft tissue sarcomas are uncommon tumors that represent 1% of all malignancies and are classified as malignant entities. The wide variety of tumor types and pathological overlap across the tumor entities make the diagnosis of soft tissue tumors difficult for pathologists. With the advancement of molecular genetic tools, our understanding of the molecular pathogenesis of soft tissue tumors has been significantly important in diagnosis, treatment, and prognosis. The role of surgery, chemotherapy, radiotherapy, target therapy, and immunotherapy are needed to identify patients who benefit from each type of treatment. This review aims to provide an update on recently described diagnostic methods and management of soft tissue sarcomas.

Soft tissue tumor sarcoma molecular pathology immunohistochemistry target therapy immunotherapy

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.